Lv6
2024 积分 2021-04-12 加入
Lu-177-Labeled Hetero-Bivalent Agents Targeting PSMA and Bone Metastases for Radionuclide Therapy
1天前
待确认
Choice of an Optimal Modular Strategy for the Synthesis of DOTA-Containing Heterobivalent Agents Targeting PSMA and GRPr
2天前
已完结
Improving Pharmacokinetics of PSMA/GRPR-Targeting Radiolabeled Heterodimer through Enhanced Albumin Binding
2天前
已完结
Evolution of PSMA-GRPr heterobivalent radiolabeled conjugates for the diagnosis and therapy of prostate cancer
4天前
已完结
Radiosynthesis, preclinical evaluation and pilot clinical PET imaging study of a 18F-labeled tracer targeting fibroblast activation protein
8天前
已完结
Gallium-68 Labeled Cyclic Glycopeptides for Liver Function Imaging
8天前
已完结
Discovery of a novel GRPR antagonist for protection against cisplatin-induced acute kidney injury
10天前
已完结
Design and Synthesis of 68Ga‐Labeled Peptide‐Based Heterodimers for Dual Targeting of NTS1 and GRPR
10天前
已完结
Two Targets, One Mission: Heterobivalent Metal‐Based Radiopharmaceuticals for Prostate Cancer Imaging and Therapy
10天前
已完结
Dual-mode biosensing platform based on red-emitting carbon dots and CeO2 nanosheets for sensitive detection of acid phosphatase and its inhibitors
17天前
已完结
皖公网安备34019202002308
